• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Malaria News / Sanaria Wins $3M Grant for Development of Malaria Vaccine

Sanaria Wins $3M Grant for Development of Malaria Vaccine

February 23, 2011 By Malaria.com 1 Comment

Sanaria has won a three-year, $3 million phase 2 Small Business Research Innovation grant from the National Institutes of Health to further develop its malaria vaccine.

The money will support research by scientists at the Rockville company and its partner, Columbia University, according to Sanaria information. The new grant continues earlier NIH-supported efforts at Sanaria and Columbia to develop genetically modified strains of the human malaria parasite Plasmodium falciparum that do not cause disease, but stimulate protective immunity when administered as a live, whole parasite malaria vaccine.

“There is considerable excitement about whole parasite malaria vaccines, and research towards developing genetically modified strains for such vaccines is at the cutting edge of this field,” said Christian Loucq, director of the Malaria Vaccine Initiative with PATH-Program for Appropriate Technology in Health, in a statement.

The parasites have been weakened by exposure to radiation and confer high-level protection against malaria when introduced by the bite of infected mosquitoes, according to Sanaria. These parasites invade host tissues, but cannot complete differentiation and do not replicate or cause disease.

“Sanaria is uniquely positioned at this time to expand the pipeline of candidate sporozoite vaccines to include vaccines based on precisely gene-altered parasites that are highly potent in inducing protective immunity against malaria and are unable to cause disease,” said Stephen L. Hoffman, Sanaria’s founder and chief scientist, in the statement.

Filed Under: Malaria News Tagged With: Christian Loucq, Malaria Vaccine, Sanaria, Small Business Research Innovation, Sporozoite Vaccines, Stephen L. Hoffman

Comments

  1. ray a. lowe says

    March 28, 2011 at 2:48 am

    I have been reading this book by a Bill something other, and I learned of Stephan Hoffman’s work on the malaria parasite and want to wish him all the spirtual luck, natural luck, human luck and what ever kind of luck it takes to eradicate this disease. You see, my very very good friend is from and has family in Gulu, Uganda and she tells me all the time how family gets malaria and all and I feel really sadden for them, as I understand it you can get malaria more than one time, and I was told that, thats is why you see lots of Africans with red eyes. I do notice the whites of their eyes is not as white as the whites of the eyes of the black people in the United states. So if Mr Hoffman can do this, all praise goes to him and that he was truly sent by god.

    Log in to Reply

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2023 Malaria.com ยท Log in